These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3680555)

  • 1. Hemodynamic and electrophysiologic effects of combined infusion of lidocaine and propafenone in humans.
    Feld GK; Nademanee K; Singh BN; Kirsten E
    J Clin Pharmacol; 1987 Jan; 27(1):52-9. PubMed ID: 3680555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine.
    Karagueuzian HS; Katoh T; McCullen A; Mandel WJ; Peter T
    Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia.
    Shen EN; Sung RJ; Morady F; Schwartz AB; Scheinman MM; DiCarlo L; Shapiro W
    J Am Coll Cardiol; 1984 May; 3(5):1291-7. PubMed ID: 6707382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic effects of propafenone in acute myocardial infarct].
    Finzi A; Ambrosini F; Pagnoni F; Massari FM; Valentini R; Lotto A
    G Ital Cardiol; 1984 May; 14(5):367-72. PubMed ID: 6468818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
    Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
    J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidocaine, mexiletine and propafenone in the treatment of arrhythmias complicating myocardial infarction. A case report.
    Aguglia F; Gnecchi M; De Marzio P
    Int J Cardiol; 1985 Mar; 7(3):303-6. PubMed ID: 2579918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of the effects of propafenone and lidocaine on early ventricular arrhythmias after acute myocardial infarction.
    Touboul P; Moleur P; Mathieu MP; Vrancea F; Ferry S; Kirkorian G; Atallah G; Marchand A; Stahl C; Zoheir F
    Eur Heart J; 1988 Nov; 9(11):1188-93. PubMed ID: 3234410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The electrophysiologic effects of enoximone in patients with preexisting ventricular tachyarrhythmias.
    Miles WM; Heger JJ; Minardo JD; Klein LS; Prystowsky EN; Zipes DP
    Am Heart J; 1989 Jan; 117(1):112-21. PubMed ID: 2521415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) (author's transl)].
    Beck OA; Vogt J; Hochrein H
    Z Kardiol; 1978 Jan; 67(1):41-5. PubMed ID: 629072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction.
    Lotto A; Finzi A; Massari FM; Pagnoni F; Valentini R; Ambrosini F; Lo Masto M
    G Ital Cardiol; 1984 Oct; 14(10):762-7. PubMed ID: 6519385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of lidocaine on impulse formation and conduction defects in man.
    Roos JC; Dunning AJ
    Am Heart J; 1975 Jun; 89(6):686-99. PubMed ID: 48330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
    Ludmer PL; McGowan NE; Antman EM; Friedman PL
    J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative investigation of the antiarrhythmic effect of propafenone (Rytmonorm) and lidocaine in patients with ventricular arrhythmias during acute myocardial infarction.
    Rehnqvist N; Ericsson CG; Eriksson S; Olsson G; Svensson G
    Acta Med Scand; 1984; 216(5):525-30. PubMed ID: 6395642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog.
    Boucher M; Chassaing C; Hamel JD; Poirier JM
    Eur J Pharmacol; 1996 Nov; 315(2):171-7. PubMed ID: 8960881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.
    Capucci A; Boriani G
    Drug Saf; 1995 Jan; 12(1):55-72. PubMed ID: 7741984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride.
    Upward JW; Daly K; Campbell S; Bergman G; Jewitt DE
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1589-95. PubMed ID: 3873868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
    Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
    J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The electrophysiologic effects of propafenone hydrochloride in the neonatal canine.
    Villafane J; Gelband H; Xu H; McCormack J; Stolfi A; Pickoff AS
    Pediatr Res; 1987 Jul; 22(1):50-4. PubMed ID: 3627871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone.
    Bellone P; Spirito P; Vecchio C
    Int J Cardiol; 1994 Mar; 43(3):335-7. PubMed ID: 8181892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.